Effect of Chronic Diseases and Multimorbidity on Survival and Functioning in Elderly Adults

Debora Rizzuto1, René J F Melis2, Sara Angleman1

  • 1Department of Neurobiology, Health Care Sciences and Society, Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden.

Insights

Multimorbidity significantly reduces lifespan and quality of life in older adults, leading to more years lived with disability. This highlights the urgent need to address multiple chronic conditions in geriatric care.

Area of Science:

  • Gerontology
  • Public Health
  • Epidemiology

Background:

  • Chronic disorders are prevalent in older adults.
  • Understanding their impact on survival and functioning is crucial for public health.
  • Co-occurrence of diseases (multimorbidity) presents unique challenges.

Purpose of the Study:

  • To determine the effect of chronic disorders and their co-occurrence on survival and functioning in community-dwelling older adults.
  • To evaluate the burden of specific diseases and multimorbidity on mortality and life years lost.
  • To assess the impact on years lived with disability.

Main Methods:

  • Population-based cohort study in Kungsholmen, Stockholm, Sweden.
  • Inclusion of 1,099 individuals aged 78 and older, followed over 11 years.
  • Evaluation of chronic diseases and multimorbidity (≥2 coexisting chronic diseases) using ICD-10 codes.

Main Results:

  • Multimorbidity affected 70.4% of the population, accounting for 69.3% of deaths and causing 7.5 years of life lost.
  • Individuals with multimorbidity lived 81% of their remaining years with disability (median 5.2 years).
  • Cardiovascular and neuropsychiatric diseases contributed significantly to mortality and years of life lost.

Conclusions:

  • Survival length and quality in older adults vary based on specific chronic conditions.
  • Multimorbidity has the most substantial negative impact on individual survival, dependence, and societal burden.
  • Multimorbidity is identified as a critical clinical and public health priority.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
293
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
283
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
291
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
771
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.0K